False positive anti-acetylcholine receptor antibodies in motorneurone disease

Long-term scarring outcomes and safety of patients treated with NovoSorbⓇ Biodegradable Temporizing Matrix (BTM): An observational cohort study.

JPRAS open·2023

Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.

Clinical radiology·2020

Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.

European journal of nuclear medicine and molecular imaging·2019

Search for the Neutron Decay n→X+γ, Where X is a Dark Matter Particle.

Physical review letters·2018

How confident are general practitioners in interpreting neuroradiology reports?

Clinical radiology·2018

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Altered sensorimotor neuroplasticity in subacute patients with non-severe burn injury.

Burns & trauma·2026

Non-coding RNAs: master regulators in the battle between host antiviral defense and viral replication.

Frontiers in immunology·2026

Inter-Assay Difference of Parathyroid Hormone Radioimmunoassay in Fine-Needle Aspirate from Neck Nodules According to Nodular Component.

Nuclear medicine and molecular imaging·2026

Reduced 24-hour heart rate variability in neurosyphilis: a retrospective case-control study.

Frontiers in neurology·2026

Evaluation of plasma neurofilament and glial fibrillary acidic protein to predict or detect amyloid related imaging abnormalities.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

The role of NEDD4-mediated ubiquitination of AQP5 in allergic rhinitis: implications for nasal mucosal barrier function.

Frontiers in immunology·2026

Related Experiment Videos

False positive anti-acetylcholine receptor antibodies in motorneurone disease

Related Concept Videos

Long-term scarring outcomes and safety of patients treated with NovoSorbⓇ Biodegradable Temporizing Matrix (BTM): An observational cohort study.

Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.

Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions.

Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.

Search for the Neutron Decay n→X+γ, Where X is a Dark Matter Particle.

How confident are general practitioners in interpreting neuroradiology reports?

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Altered sensorimotor neuroplasticity in subacute patients with non-severe burn injury.

Non-coding RNAs: master regulators in the battle between host antiviral defense and viral replication.

Inter-Assay Difference of Parathyroid Hormone Radioimmunoassay in Fine-Needle Aspirate from Neck Nodules According to Nodular Component.

Reduced 24-hour heart rate variability in neurosyphilis: a retrospective case-control study.

Evaluation of plasma neurofilament and glial fibrillary acidic protein to predict or detect amyloid related imaging abnormalities.

The role of NEDD4-mediated ubiquitination of AQP5 in allergic rhinitis: implications for nasal mucosal barrier function.

Related Experiment Videos

False positive anti-acetylcholine receptor antibodies in motorneurone disease

Related Concept Videos

Related Articles